Literature DB >> 16906721

Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap.

Shanhua Lin1, Thomas A Shaler, Christopher H Becker.   

Abstract

A method is presented to quantify intermediate-abundance proteins in human serum using a single-quadrupole linear ion trap mass spectrometer-in contrast, for example, to a triple-quadrupole mass spectrometer. Stable-isotope-labeled (tryptic) peptides are spiked into digested protein samples as internal standards, aligned with the traditional isotope dilution approach. As a proof-of-concept experiment, four proteins of intermediate abundance were selected, coagulation factor V, adiponectin, C-reactive protein (CRP), and thyroxine binding globulin. Stable-isotope-labeled peptides were synthesized with one tryptic sequence from each of these proteins. The normal human serum concentration ranges of these proteins are from 1 to 30 microg/mL (or 20 to 650 pmol/mL). These labeled peptides and their endogenous counterparts were analyzed by LC-MS/MS using multiple reaction monitoring, a multiplexed form of the selected reaction monitoring technique. For these experiments, only one chromatographic dimension (on-line reversed-phase capillary column) was used. Improved limits of detection will result with multidimensional chromatographic methods utilizing more material per sample. Standard curves of the spiked calibrants were generated with concentrations ranging from 3 to 700 pmol/mL using both neat solutions and peptides spiked into the complex matrix of digested serum protein solution where ion suppression effects and interferences are common. Endogenous protein concentrations were determined by comparing MS/MS peak areas of the endogenous peptides to the isotopically labeled internal calibrants. The derived concentrations from a normal human serum pool (neglecting loss of material during sample processing) were 9.2, 110, 120, and 246 pmol/mL for coagulation factor V, adiponectin, CRP, and thyroxine binding globulin, respectively. These concentrations generally agree with the reported normal ranges for these proteins. As a measure of analytical reproducibility of this single-quadrupole assay, the coefficients of variance based on 12 repeated measurements for each of the endogenous tryptic peptides were 17.0, 25.4, 24.2, and 14.0% for coagulation factor V, adiponectin, CRP, and thyroxine binding globulin, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906721     DOI: 10.1021/ac060613f

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  21 in total

1.  A computational tool to detect and avoid redundancy in selected reaction monitoring.

Authors:  Hannes Röst; Lars Malmström; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2012-04-24       Impact factor: 5.911

2.  Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Heidi Y Zhang; Li-Chia Feng; Brian D Piening; Leigh Anderson; Amanda G Paulovich
Journal:  Anal Biochem       Date:  2006-12-20       Impact factor: 3.365

3.  Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution.

Authors:  Hasmik Keshishian; Terri Addona; Michael Burgess; Eric Kuhn; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2007-10-15       Impact factor: 5.911

Review 4.  Biomarker method validation in anticancer drug development.

Authors:  J Cummings; T H Ward; A Greystoke; M Ranson; C Dive
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

5.  Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests.

Authors:  Tanguy Fortin; Arnaud Salvador; Jean Philippe Charrier; Cristof Lenz; Xavier Lacoux; Aymeric Morla; Geneviève Choquet-Kastylevsky; Jérôme Lemoine
Journal:  Mol Cell Proteomics       Date:  2008-12-08       Impact factor: 5.911

6.  Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma.

Authors:  Michael A Kuzyk; Derek Smith; Juncong Yang; Tyra J Cross; Angela M Jackson; Darryl B Hardie; N Leigh Anderson; Christoph H Borchers
Journal:  Mol Cell Proteomics       Date:  2009-05-01       Impact factor: 5.911

Review 7.  Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.

Authors:  Anastasia K Yocum; Arul M Chinnaiyan
Journal:  Brief Funct Genomic Proteomic       Date:  2009-03-11

Review 8.  Recent developments in quantitative proteomics.

Authors:  Christopher H Becker; Marshall Bern
Journal:  Mutat Res       Date:  2010-07-08       Impact factor: 2.433

9.  Multiple liquid chromatography separations and nanoESI-ion trap detection of plasma proteins in search of stroke biomarkers: A pilot study.

Authors:  Phanichand Kodali; Agnese Jurkevica; Julio Landero; Christopher Kuhlmann; Joseph Caruso; Opeolu Adeoye
Journal:  J Sep Sci       Date:  2012-07-16       Impact factor: 3.645

10.  MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides.

Authors:  Xu Yang; Iulia M Lazar
Journal:  BMC Cancer       Date:  2009-03-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.